BioPharma Dive ١٨ ديسمبر ٢٠٢٥ Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial
BioPharma Dive ١٨ ديسمبر ٢٠٢٥ Insmed’s ‘win streak’ ends as top drug fails study in chronic nasal condition
BioPharma Dive ١٨ ديسمبر ٢٠٢٥ Orum, a biotech marrying ADCs with protein degraders, captures $100M in funding
BioPharma Dive ١٧ ديسمبر ٢٠٢٥ Peanut allergy patch succeeds in late-stage study 5 years after FDA rejection
BioPharma Dive ١٧ ديسمبر ٢٠٢٥ Addition emerges with $100M to make gene therapies for chronic and rare diseases
BioPharma Dive ١٦ ديسمبر ٢٠٢٥ Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study